Bioinformatics & Systems Biology
Global

Bioinformatics & Systems Biology Experts

Xiaoqing Yu

Researcher
Deparment of Biostatistics and Bioinformatics
Moffitt Cancer Center
United States of America

Biography

Dr. Xiaoqing Yu is affiliated to Deparment of Biostatistics and Bioinformatics, Moffitt Cancer Center. Dr. Xiaoqing Yu is currently providing services as Researcher. Dr. Xiaoqing Yu has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Xiaoqing Yu contributions have acclaimed recognition from honourable subject experts around the world. Dr. Xiaoqing Yu is actively associated with different societies and academies. Dr. Xiaoqing Yu academic career is decorated with several reputed awards and funding. Dr. Xiaoqing Yu research interests include Her particular areas of research focus and interest include: 1) Studying the immune-tumor interaction across cancer types and building predictive models for patients’ response to immunotherapy; and 2) Statistical and bioinformatics methods development to identify aberrant methylation patterns in tumors using bisulfite sequencing data. .

Research Interest

Her particular areas of research focus and interest include: 1) Studying the immune-tumor interaction across cancer types and building predictive models for patients’ response to immunotherapy; and 2) Statistical and bioinformatics methods development to identify aberrant methylation patterns in tumors using bisulfite sequencing data. 

Publications

  • Charkoftaki G, Chen Y, Han M, Sandoval M, Yu X, Zhao H, Orlicky DJ, Thompson DC, Vasiliou V. Transcriptomic analysis and plasma metabolomics in Aldh16a1-null mice reveals a potential role of ALDH16A1 in renal function. Chemico-Biological Interactions. 2017 Feb 28.

  • Chorzalska A, Kim JF, Roder K, Tepper A, Ahsan N, Rao RS, Olszewski AJ, Yu X, Terentyev D, Morgan J, Treaba DO. Long-term exposure to imatinib mesylate downregulates Hippo pathway and activates YAP in a model of chronic myelogenous leukemia. Stem cells and development. 2017 May 1;26(9):656-77.

  • Heit C, Marshall S, Singh S, Yu X, Charkoftaki G, Zhao H, Orlicky DJ, Fritz KS, Thompson DC, Vasiliou V. Catalase deletion promotes prediabetic phenotype in mice. Free Radical Biology and Medicine. 2017 Feb 28;103:48-56.

Global Experts from United States of America

Global Experts in Subject

Share This Profile